A ODC Life Sciences atua como parceira estratégica de empresas biofarmacêuticas, facilitando o acesso a uma ampla e diversificada população de pacientes em toda a América Latina.
Com foco no recrutamento de pacientes, dedicamos todas as nossas atividades a apoiar nossos parceiros na identificação e seleção dos participantes ideais para cada ensaio clínico, garantindo precisão, agilidade e resultados de alta qualidade.
A América Latina oferece às empresas biofarmacêuticas globais uma oportunidade única de recrutar pacientes de uma população menos competitiva e com menor tratamento prévio.
Comprehensive training programs and workshops to enhance awareness of research capabilities and patient engagement.
Partnership programs with patient advocacy groups and community leaders to build trust and awareness.
Strategic site selection and activation leveraging data-driven insights across LATAM.
Leverage our extensive LATAM patient databases for targeted recruitment and accelerated enrollment.
Targeted digital campaigns and online engagement to inform healthcare professionals and facilitate patient access.
Interactive webinars and online resources to educate patients on clinical research opportunities.
Estudos clínicos: LATAM/EUA
Deep regional knowledge and established networks across Latin America.
Across Latin America
Experienced research centers
Trusted partnerships
Across sponsors
Nossos serviços:
E os add-ons:
E os add-ons:
E os add-ons:
Specialized experience in rare diseases and complex therapeutic indications.
Case study
Case Study – Oncology: ODC Turned Brazil into the World’s #1 Country for a Biomarker-Selected Global Precision Oncology Trial (GIST) Challenge The INSIGHT Phase III trial — evaluating ripretinib vs. sunitinib in advanced GIST — required patients with a highly
Case study
Case Study – Rare-Disease: ODC Implemented a Three-Pillar Strategy to Unlock LATAM for a Global Ultra-Rare Kidney Disease Trial Challenge The sponsor needed to recruit patients with C3G and IC-MPGN — two ultra-rare complement-mediated kidney diseases — for the Phase
Case study
Case Study – Hematology: ODC Implemented a High-Touch Recruitment Model to Make Brazil a Decisive Late-Stage Accelerator in a Global Rare Hematology Trial Challenge The sponsor needed to recruit patients with myelofibrosis and severe thrombocytopenia (platelets <50,000/μL) for the Phase
White paper
Clinical research faces a critical and persistent challenge: the difficulty of recruiting patients efficiently at scale. Today, traditional markets such as the United States and Europe are experiencing significant saturation in clinical trial sites, where a finite pool of eligible
Estudos clínicos: LATAM/EUA
Brazil
9.077
215 M
23.686
MEXICO
4.604
127 M
27.585
ARGENTINA
3.563
45 M
12.630
CHILE
2.014
19 M
9.732
COLOMBIA
1.745
52 M
29.799
PERU
1.184
33 M
28.289
LATAM
22.187
492 M
22.175
EUA
158.782
339 M
2.135
é composto por uma população extremamente plural
Caucasianos
43%
31%
57,8%
85-90%
0%
Negros
9,1%
8%
12,1%
2-4%
0%
Mestiços/Latinos
46,8%
58%
24,2%
3-7%
1%
Asiáticos
1,1%
3%
5,9%
2-4%
99%
significa testes clínicos mais rápidos e baratos
100%
EUA
69%
Argentina
62%
Germany
58%
Belgium
53%
United Kingdom
51%
Russia
46%
Poland
44%
Brazil
39%
Netherlands